II edición RESPrimaria, 7 de mayo de 2025
abril 28, 2025
No te pierdas la II edición RESPrimaria el próximo 7 de mayo. Inscríbete en formato Streaming o solicita tu invitación presencial. ¡Plazas limitadas!
No te pierdas la II edición RESPrimaria el próximo 7 de mayo. Inscríbete en formato Streaming o solicita tu invitación presencial. ¡Plazas limitadas!
Proteomic Predictors of Mortality in Stable COPD is the objective of this pilot study. It searchs to identify proteomic markers and specific multiprotein signatures that could be useful in predicting long-term mortality
Siprometry to diagnose COPD: GOLD 2025 recommends using pre-BD spirometry to rule out COPD and post-BD to confirm, ensuring volume responders are not overlooked.
Climate change and COPD are linked through extreme temperature, wildfire smoke, dust storms and allergen exposure, which pose major health threats.
Descubre los avances en el diagnóstico y tratamiento de la EPOC con el Dr. Alvar Agustí en la II Jornada SEMG Resprimaria. Conoce la importancia de la espirometría, la detección precoz y las nuevas estrategias terapéuticas.
Artificial Intelligence in COPD is transforming disease management, from underdiagnosis to treatment guidance. Discover how machine learning clusters patients, predicts outcomes, and optimizes healthcare resources.
NOVEDADES GOLD 2025, Reunión mixta el próximo 19 de Noviembre 2024, de 17:30 a 19h. Asistencia gratuita, pero precisa registro on-line. Link de registro aquí.
Artificial Intelligence in Respiratory Medicine GOLD Webinar · 6 de Mayo del 2024.
The diagnosis of COPD requires the demonstration of non-fully reversible airflow limitation by spirometry in the appropriate clinical context.
Since 2001 the GOLD publishes and updates every year a document that recommends how to best diagnose and manage COPD. The GOLD 2024 document has just been released and is available for free download in the GOLD website.